Literature DB >> 15277614

Hereditary dementia with intracerebral hemorrhages and cerebral amyloid angiopathy.

A M Remes1, S Finnilä, H Mononen, H Tuominen, R Takalo, R Herva, K Majamaa.   

Abstract

BACKGROUND: Deposition of the beta-amyloid peptide (Abeta) in neuritic plaques is a hallmark of Alzheimer disease (AD). Mutations in genes encoding amyloid precursor protein (APP) and presenilin 1 and 2 (PSEN1, PSEN2) are associated with increased accumulation of Abeta in neuritic plaques or in the walls of cerebral vessels. Intracerebral hemorrhage occasionally affects patients with AD.
METHODS: A Finnish family with dementia in four generations and with frequent co-occurrence of dementia and intracerebral hemorrhage was identified. Clinical features of 14 family members with a cognitive decline were evaluated. All exons in genes encoding APP, PSEN1, PSEN2, cystatin C, transthyretin, gelsolin, and ITM2B were sequenced, and an association study of APP was conducted by identification of single-nucleotide polymorphisms.
RESULTS: Neuropathologic examination revealed Alzheimer-type changes with Abeta in neuritic plaques and vessel walls, but the cognitive profile of the patients differed from that in AD, as the visuoconstructive functions and verbal fluency were well preserved even in the moderate stage of the disease. In addition to cognitive decline, five patients had had lobar intracerebral hemorrhages and one was diagnosed with hemosiderin deposits in MRI, suggesting previous cerebral microbleeds. No causative mutations were identified in candidate genes associated with amyloid diseases, but linkage to APP region could not be entirely excluded.
CONCLUSIONS: The family presents an autosomal dominant form of beta-amyloidogenic disease that resembles the Italian, Flemish, and Iowa types of AD. No amyloidogenic mutations were identified, but the role of the APP region could not be entirely excluded.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15277614     DOI: 10.1212/01.wnl.0000129988.68657.fa

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage.

Authors:  A Rovelet-Lecrux; T Frebourg; H Tuominen; K Majamaa; D Campion; A M Remes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-18       Impact factor: 10.154

Review 2.  Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities.

Authors:  Christiane Reitz
Journal:  Expert Rev Mol Diagn       Date:  2015-01-29       Impact factor: 5.225

Review 3.  Network abnormalities and interneuron dysfunction in Alzheimer disease.

Authors:  Jorge J Palop; Lennart Mucke
Journal:  Nat Rev Neurosci       Date:  2016-11-10       Impact factor: 34.870

Review 4.  Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.

Authors:  Ann D Cohen; Gil D Rabinovici; Chester A Mathis; William J Jagust; William E Klunk; Milos D Ikonomovic
Journal:  Adv Pharmacol       Date:  2012

Review 5.  The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE.

Authors:  Rita J Guerreiro; Deborah R Gustafson; John Hardy
Journal:  Neurobiol Aging       Date:  2010-07-01       Impact factor: 4.673

6.  Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series.

Authors:  Daniel McNaughton; William Knight; Rita Guerreiro; Natalie Ryan; Jessica Lowe; Mark Poulter; David J Nicholl; John Hardy; Tamas Revesz; James Lowe; Martin Rossor; John Collinge; Simon Mead
Journal:  Neurobiol Aging       Date:  2010-12-28       Impact factor: 4.673

Review 7.  Intracerebral haemorrhage in Down syndrome: protected or predisposed?

Authors:  Lewis Buss; Elizabeth Fisher; John Hardy; Dean Nizetic; Jurgen Groet; Laura Pulford; André Strydom
Journal:  F1000Res       Date:  2016-05-12

Review 8.  New Insights into the Molecular Bases of Familial Alzheimer's Disease.

Authors:  Valeria D'Argenio; Daniela Sarnataro
Journal:  J Pers Med       Date:  2020-04-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.